0002014427-24-000002.txt : 20240517 0002014427-24-000002.hdr.sgml : 20240517 20240517141943 ACCESSION NUMBER: 0002014427-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 EFFECTIVENESS DATE: 20240517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Progentos Therapeutics, Inc. CENTRAL INDEX KEY: 0002014427 ORGANIZATION NAME: IRS NUMBER: 932871016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-513638 FILM NUMBER: 24958943 BUSINESS ADDRESS: STREET 1: 200 DEXTER AVENUE CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-363-0218 MAIL ADDRESS: STREET 1: 200 DEXTER AVENUE CITY: WATERTOWN STATE: MA ZIP: 02472 D 1 primary_doc.xml X0708 D LIVE 0002014427 Progentos Therapeutics, Inc. 200 DEXTER AVENUE WATERTOWN MA MASSACHUSETTS 02472 857-363-0218 DELAWARE None None Corporation true 2023 Christopher Loose 200 Dexter Ave Watertown MA MASSACHUSETTS 02472 Executive Officer Director Dmitrij Hristodorov 200 Dexter Ave Watertown MA MASSACHUSETTS 02472 Director Marc-Olivier Turgeon 200 Dexter Ave Watertown MA MASSACHUSETTS 02472 Director Aleks Radovic-Moreno 200 Dexter Ave Watertown MA MASSACHUSETTS 02472 Director Cassidy Blundell 200 Dexter Ave Watertown MA MASSACHUSETTS 02472 Director Dan Janney 200 Dexter Ave Watertown MA MASSACHUSETTS 02472 Director Sanjay Magavi 200 Dexter Ave Watertown MA MASSACHUSETTS 02472 Executive Officer Other Decline to Disclose 06b false 2024-05-03 false true true Includes conversion of convertible notes false 0 68588739 68588739 0 false 39 0 0 0 false Progentos Therapeutics, Inc. /s/ Christopher Loose Christopher Loose CEO 2024-05-14